Connecticut Wealth Management, LLC Dexcom Inc Transaction History

Connecticut Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$67.99 - $132.89 $42,221 - $82,524	-621 Closed	0 $0
Q1 2022 Apr 18, 2022	SELL	$94.08 - $130.2 $282 - $390	-3 Reduced 0.48%	621 $318,000
Q3 2021 Nov 02, 2021	BUY	$106.71 - $143.18 $2,134 - $2,863	20 Added 3.31%	624 $341,000
Q2 2021 Jul 29, 2021	BUY	$80.99 - $107.93 $48,917 - $65,189	604 New	604 $258,000

1,020

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $32.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Connecticut Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Connecticut Wealth Management, LLC with notifications on news.